טוען...
First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
BACKGROUND AND AIM: To investigate the efficacy of platinum-based chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma (mGEP-NEC) and define predictive and prognostic factors. METHODS: Twenty mGEP-NEC patients were treated with cisplatin or carboplatin/etoposide b...
שמור ב:
| הוצא לאור ב: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4671803/ https://ncbi.nlm.nih.gov/pubmed/26664145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S91971 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|